一个全面的回顾目前的前景和肺结核病的未来前景
Xiaomin Hou1,2,3, Zhengqian Wei4, Xuelu Jiang2,5
1Department of Pharmacology, Shanxi Medical University, Taiyuan, Shanxi, China.
Frontiers in public health
|January 27, 2025
概括
肺结核病是一种吸入尘埃的肺部疾病,会引起炎症和纤维化. 新的研究探索先进的治疗方法,如人工智能和细胞疗法,以更好地控制和新的治疗目标.
科学领域:
- 职业医学 职业医学 职业医学
- 肺部病理学 肺部病理学
- 毒理学 毒理学 毒理学
背景情况:
- 肺结核病是一种严重的职业肺部疾病,由吸入灰尘引起.
- 它导致慢性炎症,纤维化,并可能导致呼吸或心力衰竭.
- 矿业,造业和建筑业的工人面临高风险.
研究的目的:
- 综合有关肺炎症分类,流行病学,预防和临床方面的当前知识.
- 审查了解肺结核病的病变发生的最新进展.
- 突出新兴的治疗策略和肺结核病治疗和控制的未来方向.
主要方法:
- 国际和国家分类的综合文献综述.
- 综合流行病学数据和预防策略.
- 分析当前关于致病的研究,包括细胞机制和促成因素.
主要成果:
- 肺结核病的发病包括自,亡和热亡.
- 脂聚糖和尼古丁被确定为疾病发展的关键因素.
- 新兴技术,如整合性奥米克,人工智能,和介酶体 stromal 细胞疗法显示出承诺.
结论:
- 肺结核病需要多方面的预防和治疗方法.
- 了解细胞机制对于开发向疗法至关重要.
- 创新技术为管理和潜在地治愈肺结核病提供了新的希望.
相关概念视频
Pneumonia III: Complications and Assessment
151
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
151
Pneumothorax-II
118
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
118
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Pneumonia I: Introduction
205
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


